Freenome, Inc. Investment Income, Interest
Freenome, Inc. (FRNM) reported Investment Income, Interest of $339.77 thousand for the 3-month period ending 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-18
- Freenome, Inc. investment income, interest for the quarter ending 2026-06-30 was $339.77K, a 64.19% decline year-over-year.
- Freenome, Inc. investment income, interest for the quarter ending 2026-03-31 was $841.18K, a 12.55% decline year-over-year.
- Freenome, Inc. investment income, interest for the quarter ending 2025-12-31 was $937.89K, a 6.24% decline year-over-year.
- Freenome, Inc. investment income, interest for the quarter ending 2025-09-30 was $972.60K, a 16.40% decline year-over-year.
| Period end | Investment Income, Interest 0 month | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $339.77K S-1 · filed 2026-08-18 | $1.18M S-1 · filed 2026-08-18 | $2.12M derived: sum of 3 quarters · filed 2026-08-18 | $3.09M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2026-03-31 | $841.18K S-4/A · filed 2026-06-11 | $1.78M derived: sum of 2 quarters · filed 2026-08-18 | $2.75M derived: sum of 3 quarters · filed 2026-08-18 | $3.70M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-12-31 | $937.89K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-18 | $1.91M derived: sum of 2 quarters · filed 2026-08-18 | $2.86M derived: sum of 3 quarters · filed 2026-08-18 | $3.82M S-1 · filed 2026-08-18 | |
| 2025-09-30 | $972.60K 10-Q · filed 2025-11-13 | $1.92M derived: sum of 2 quarters · filed 2026-08-18 | $2.88M 10-Q · filed 2025-11-13 | $3.88M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-06-30 | $948.92K S-1 · filed 2026-08-18 | $1.91M S-1 · filed 2026-08-18 | $2.91M derived: sum of 3 quarters · filed 2026-08-18 | $4.07M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2025-03-31 | $961.91K S-4/A · filed 2026-06-11 | $1.96M derived: sum of 2 quarters · filed 2026-08-18 | $3.13M derived: sum of 3 quarters · filed 2026-08-18 | $3.33M derived: sum of 4 quarters · filed 2026-08-18 | |
| 2024-12-31 | $1.00M derived: S-1 9 month − 10-Q 6 month · filed 2026-08-18 | $2.16M derived: sum of 2 quarters · filed 2026-08-18 | $2.37M S-1 · filed 2026-08-18 | ||
| 2024-09-30 | $1.16M 10-Q · filed 2025-11-13 | $1.37M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $202.33K 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |